GP-Act III Acquisition Corp. (NASDAQ:GPAT – Get Free Report) was the recipient of a large decline in short interest in July. As of July 31st, there was short interest totaling 2,049 shares, a decline of 41.1% from the July 15th total of 3,478 shares. Based on an average daily volume of 37,374 shares, the short-interest ratio is presently 0.1 days.
GP-Act III Acquisition Price Performance
Shares of NASDAQ:GPAT traded down $0.12 during midday trading on Tuesday, hitting $11.04. 734 shares of the stock were exchanged, compared to its average volume of 128,407. GP-Act III Acquisition has a 52-week low of $10.50 and a 52-week high of $12.00. The business’s fifty day simple moving average is $11.01 and its two-hundred day simple moving average is $10.89.
GP-Act III Acquisition (NASDAQ:GPAT – Get Free Report) last issued its earnings results on Friday, August 14th. The company reported $0.01 earnings per share for the quarter.
Analyst Ratings Changes
Read Our Latest Research Report on GPAT
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of the business. TENOR CAPITAL MANAGEMENT Co. L.P. acquired a new stake in shares of GP-Act III Acquisition in the 2nd quarter valued at $7,800,000. L1 Global Manager Pty Ltd acquired a new stake in shares of GP-Act III Acquisition in the fourth quarter worth about $6,067,000. Berkley W R Corp lifted its position in shares of GP-Act III Acquisition by 171.2% in the first quarter. Berkley W R Corp now owns 846,823 shares of the company’s stock worth $9,180,000 after buying an additional 534,533 shares during the last quarter. Westchester Capital Management LLC boosted its stake in shares of GP-Act III Acquisition by 22.5% during the 4th quarter. Westchester Capital Management LLC now owns 1,360,852 shares of the company’s stock worth $14,561,000 after acquiring an additional 250,000 shares in the last quarter. Finally, JPMorgan Chase & Co. acquired a new position in shares of GP-Act III Acquisition during the 2nd quarter valued at about $2,377,000.
About GP-Act III Acquisition
GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.
Featured Stories
- Five stocks we like better than GP-Act III Acquisition
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
